Back to User profile » Dr Paulien Ravenstijn

Papers published by Dr Paulien Ravenstijn:

Original Research

Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Hargarter L

Neuropsychiatric Disease and Treatment 2019, 15:587-602

Published Date: 21 February 2019

Original Research

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ

Neuropsychiatric Disease and Treatment 2017, 13:2193-2207

Published Date: 17 August 2017